What is AOR?
Founded in 1991, AOR operates at the intersection of clinical research and natural health. The company distinguishes itself through a commitment to evidence-based formulations, moving beyond standard supplement offerings to provide targeted support for complex physiological systems. Their product portfolio, which includes advanced capsules, powders, and softgels, is developed in collaboration with academic and research institutions to ensure maximum bioavailability and efficacy. By prioritizing transparency and manufacturing excellence, AOR has established itself as a trusted authority in the nutraceutical industry, catering to a sophisticated clientele that demands scientific validation for their health regimens.
How much funding has AOR raised?
AOR has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in AOR
PPP
Public-Private Partnership
What's next for AOR?
With the recent influx of capital, AOR is poised to accelerate its strategic growth initiatives. The company is expected to focus on scaling its manufacturing capabilities and deepening its research partnerships to maintain its competitive edge in the global health market. Future efforts will likely center on diversifying its product range to address emerging health trends while maintaining the rigorous quality standards that have defined its brand for over three decades. As the company transitions into this next phase of development, the focus remains on leveraging its scientific foundation to capture additional market share and drive innovation in personalized health solutions.
See full AOR company page
